Influenza and Pneumococcal Vaccinations in the Emergency Department

Emergency Medicine Clinics of North America

Volumn 26, Issue 2, 2008, Pages 549-570

  Martin, Daniel R ^a   Brauner, Mark E ^a   Plouffe, Joseph F ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; OSELTAMIVIR; PNEUMOCOCCUS VACCINE; ZANAMIVIR;

ANTIVIRAL THERAPY; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMORBIDITY; DRUG EFFICACY; EMERGENCY WARD; ERYTHEMA; FEVER; HEALTH CARE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INFLUENZA; INJECTION SITE PAIN; LOBAR PNEUMONIA; MEDICARE; MORBIDITY; MORTALITY; MUCOSAL IMMUNITY; MYALGIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SWELLING; VACCINATION;

EID: 41749115499     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2008.02.004     Document Type: Review

References (102)

1. Nawar E.W., Niska R.W., and Jianmin X. re Statistics National Hospital Ambulatory Medical Care Survey: 2005 Emergency Department summary. Available at:. http://www.cdc.gov/nchs/data/ad/ad386.pdf Accessed February 4, 2008
2. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 (2007) S27-S72
3. Pallin D.J., Muennig P.A., Emond J.A., et al. Vaccination practices in U.S. emergency departments. Vaccine 23 (2005) 1048-1052
4. Talan D.A., Abrahamian F.M., Moran G.J., et al. Tetanus immunity and physician compliance with tetanus prophylaxis practices among ED patients presenting with wounds. Ann Emerg Med 43 (2004) 305-314
5. Pascual F.B., McGinley E.L., Zanardi L.R., et al. Tetanus surveillance US 1998-2000. MMWR Surveill Summ 52 (2003) 1-8
6. Thwaites C.L., and Farrar J.J. Preventing and treating tetanus. BMJ 326 (2003) 117-118
7. Vandelaer J., Birmingham M., Gasse F.L., et al. Tetanus in developing countries: an update on the maternal and neonatal tetanus elimination initiative. Vaccine 21 (2003) 3442-3445
8. Center for Disease Control and Prevention (CDC). Influenza and pneumococcal vaccination levels among persons aged >65 years-United States, 1999. MMWR Morb Mortal Wkly Rep 50 (2001) 532-537
9. Bridges C.B., Fukuda K., Cox N.J., et al. Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep 50 RR-4 (2001) 1-44
10. CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 46 RR-8 (1997) 1-24
11. Bratzler D.W., Houck P.M., Jiang H., et al. Failure to vaccinate Medicare inpatients. Arch Intern Med 162 (2002) 2349-2356
12. Association for Practitioners of Infection Control. Position paper: immunizations. Am J Infect Control 20 (1992) 131-132
13. Fedson D.S. Adult immunization. Summary of the National Vaccine Advisory Committee. JAMA 272 (1994) 1133-1137
14. Fisman D.N., Abrutyn E., Spaude K.A., et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community acquired pneumonia. Clin Infect Dis 42 (2006) 1093-1101
15. Gross P.A., Hermogenes A.W., Sacks H.S., et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 123 (1995) 518-527
16. Nichol K.L., Baken L., and Nelson A. Relation between influenza vaccination and outpatient visits, hospitalizations, and mortality in elderly persons with chronic lung disease. Ann Intern Med 130 (1999) 397-403
17. McDonald C.J., Hui S.L., and Tiemey W.M. Effects of computer reminders for influenza vaccination on morbidity during influenza epidemics. MD Comput 9 (1992) 304-312
18. Nichol K.L., Margolis K.L., Wuorenma J., et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 331 (1994) 778-784
19. Sisk J.E., Moskowitz A.J., Whang W., et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 278 (1997) 1333-1339
20. Polis M.A., Smith J.P., Sainer D., et al. Prospects for an emergency department-based adult immunization program. Arch Intern Med 147 (1987) 1999-2001
21. Polis M.A., Davey V.J., Collins E.D., et al. The emergency department as part of a successful strategy for increasing adult immunization. Ann Emerg Med 17 (1988) 1016-1018
22. Rodriguez R.M., and Baraff L.J. Emergency department immunization of the elderly with pneumococcal and influenza vaccines. Ann Emerg Med 22 (1993) 1729-1732
23. Wrenn K., Zeldin M., and Miller O. Influenza and pneumococcal vaccination in the ED: is it feasible?. J Gen Intern Med 9 (1994) 425-429
24. Kapur A.K., and Tenenbein M. Vaccination of ED patients at high risk for influenza. Acad Emerg Med 7 (2000) 354-358
25. Slobodkin D., Zielske P.G., Kitlas J.L., et al. Demonstration of the feasibility of ED immunization against influenza and pneumococcus. Ann Emerg Med 32 (1998) 537-543
26. Stack S.J., Martin D.R., and Plouffe J.F. An emergency department-based pneumococcal vaccination program could save money and lives. Ann Emerg Med 33 (1999) 299-303
27. Hussain S., Slobodkin D., and Weinstein R.A. Pneumococcal vaccination: analysis of opportunities in an inner city hospital. Arch Intern Med 162 (2002) 1961-1965
28. Schull M.J., Mamdani M.M., and Fang J. Influenza and ED utilization by elders. Acad Emerg Med 12 (2005) 338-344
29. Silka P.A., Geiderman J.M., Goldberg J.B., et al. Demand on ED resources during periods of widespread influenza activity. Am J Emerg Med 21 (2003) 534-539
30. Schull M.J., Mamdani M.M., and Fang J. Community influenza and emergency department ambulance diversion. Ann Emerg Med 44 (2004) 61-67
31. Menec V.H., Black C., MacWilliam L., et al. The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, ER visits and mortality. Can J Public Health 94 (2003) 59-63
32. American College of Emergency Physicians Council (ACEP). Resolution 18, influenza and pneumococcal immunizations. Available at:. http://www.acep.org/Content.aspx?id=23216
33. ACEP. Immunization of adult patients. Available at:. http://www.acep.org/practres.aspx?id=29516 Accessed December 1, 2007
34. ACEP. Immunizations in the ED. Available at:. http://www.acep.org/practres.aspx?id=29522 Accessed December 1, 2007
35. Butler J.C., Shapiro E.D., and Carlone G.M. Pneumococcal vaccines: history, current status and future directions. Am J Med 107 1A (1999) 69S-76S
36. Centers for Medicare and Medicaid Services. 2001 Fact sheet for Medicare influenza/pneumococcal vaccination benefits. Available at:. http://cms.hhs.gov/preventiveservices/2.asp#1 Accessed April 8, 2002
37. CDC. Healthy People 2010 database. Available at:. http://wonder.cdc.gov/data2010/ Accessed January 22, 2008
38. Center for Disease Control and Prevention. Recommended childhood immunization schedule-United States. JAMA 279 (1998) 495-496
39. CDC. National Immunization Survey 2005 Report. Available at:. http://www.cdc.gov/vaccines/stats-surv/nis/data/tables_2005.htm Accessed January 22, 2008
40. CDC. National Immunization Survey 2006 Report. Available at:. http://www.cdc.gov/vaccines/stats-surv/nis/data/tables_2006.htm Accessed January 22, 2008
41. Kroger A.T., Atkinson W.L., Marcuse E.K., et al. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 55 RR15 (2006) 1-48
42. Fiore A.E., Shay D.K., Haber P., et al. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control an Prevention (CDC). Prevention and control of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 56 RR06 (2007) 1-54
43. Morens D.M. Influenza-related mortality: considerations for practice and public health. JAMA 289 (2003) 227-229
44. Brundage J.F. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 6 (2006) 303-312
45. Neuzil K.M., Mellen B.G., Wright P.F., et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 342 (2000) 225-231
46. Monto A.S., and Sullivan K.M. Acute respiratory illness in the community: frequency of illness and the agents involved. Epidemiol Infect 110 (1993) 145-160
47. Lutwick S. Pediatric vaccine compliance. Pediatr Clin North Am 47 (2000) 427-434
48. Esposito S., Marchisio P., Droghetti R., et al. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine 24 (2006) 5251-5255
49. Atkinson W., and Hamborsky J. CDC epidemiology and prevention of vaccine-preventable diseases. 10th edition (2007), Public Health Foundation, Washington, DC
50. National Vaccine Advisory Committee. Standards for child and adolescent immunization practices: National Vaccine Advisory Committee. Pediatrics 112 (2003) 958-963
51. Pappano D., Humiston S., and Goepp J. Efficacy of a pediatric ED based influenza vaccination program. Arch Pediatr Adolesc Med 158 (2004) 1077-1083
52. Humiston S.G., Lerner E.B., Hepworth E., et al. Parent opinions about universal influenza vaccination for infants and toddlers. Arch Pediatr Adolesc Med 159 (2005) 108-112
53. Gurfinkel E.P., Leon de la Fuente R., Mendiz O., et al. Flu Vaccination in Acute Coronary Syndromes and Planned Percutaneous Coronary Interventions (FLUVACS) study. Eur Heart J 25 (2004) 25-31
54. Jackson L.A., Yu O., Heckbert S.R., et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 156 (2002) 634-640
55. Cates C.J., Jefferson T.O., Bara A.I., et al. Vaccines for preventing influenza in people with asthma (Cochrane Review). Cochrane Database Syst Rev 4 (2000) CD000364
56. Smits A.J., Hak E., Stallman W.A., et al. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect 128 (2002) 205-211
57. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma (1997), 146 US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda (MD)
58. Taubenberger J.K., and Morens D.M. 1918 influenza: the mother of all pandemics. Emerg Infect Dis (2006). http://www.cdc.gov/ncidod/EID/vol12no01/05-0979.htm Accessed January 22, 2008
59. Cox N.J., and Fukuda K. Influenza. Infect Dis Clin North Am 12 (1998) 27-38
60. Monmany J., Rabella N., Margall N., et al. Unmasking influenza virus infection in patients attended to in the ED. Infection 32 (2004) 89-97
61. Long C.E., Hall C.B., Cunningham C.K., et al. Influenza surveillance in community-dwelling elderly compared with children. Arch Fam Med 6 (1997) 459-465
62. Cunha B. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 18 (2004) 141-155
63. Simonsen L., Taylor R.J., Viboud C., et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7 (2007) 658-666
64. The World Health Organization (WHO). Global Influenza Surveillance Network. Available at:. http://www.who.int/csr/disease/influenza/influenzanetwork/en/index.html Accessed January 22, 2008
65. Reid K.C., Grizarrd T.A., and Poland G.A. Adult immunizations: recommendations for practice. Mayo Clin Proc 74 (1999) 377-384
66. Ball L.K., Ball R., and Pratt R.D. An assessment of thimerosal use in childhood vaccines. Pediatrics 107 5 (2001) 1147-1154
67. Juurlink D.N., Stukel T.A., Kwong J., et al. Guillain-Barré syndrome after influenza vaccination in adults; a population-based study. Arch Intern Med 166 (2006) 2217-2221
68. United States Government Accountability Office (GAO). GAO Report to the Committee on Oversight and Government Reform, House of Representatives: INFLUENZA VACCINE issues related to production, distribution, and public health messages, October 2007. Available at:. http://www.gao.gov/new.items/d0827.pdf Accessed January 22, 2008
69. Homeland Security Council. The White House: National Strategy for Pandemic Influenza Implementation Plan One Year Summary, July 17, 2007. Available at:. http://www.whitehouse.gov/homeland/pandemic-influenza-oneyear.html Accessed January 22, 2008
70. Negri E., Colombo C., Giordano L., et al. Influenza vaccine in healthy children: a meta-analysis. Vaccine 23 (2005) 2851-2861
71. Belshe R., and Mendelman P. Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent. Immunol Allergy Clin North Am 23 (2003) 745-767
72. Witte K., and Allen M. A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav 27 (2000) 591-615
73. Hak E., Hoes A.W., Nordin J., et al. Benefits of influenza vaccine in US elderly-appreciating issues of confounding bias and precision. Int J Epidemiol 35 (2006) 800-802
74. Jackson L.A., Jackson M.L., Nelson J.C., et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35 (2006) 337-344
75. Nichol K.L. Benefits of influenza vaccination among healthy and high-risk persons across the age spectrum. International Congress Series 1263 (2004) 48-50
76. Zangwill K.M., and Belshe R.B. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary of the new era of routine vaccination. Pediatr Infect Dis J 23 (2004) 189-197
77. Neuzil K.M., Dupont W.D., Wright P.F., et al. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 20 (2001) 733-740
78. Nichol K.L., Nordin J.D., Nelson N.B., et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357 (2007) 1373-1381
79. Nichol K.L., Nordin J., Mullooly J., et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 348 (2003) 1322-1332
80. Gillim-Ross L., and Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev 19 (2006) 614-636
81. Giovanetti F. Travel medicine interventions and neurological disease. Travel Med Infect Dis 5 (2007) 7-17
82. Zanetti A.R., Amendola A., Besana S., et al. Safety and immunogenicity of influenza vaccination in individuals infected with HIV. Vaccine 20 Suppl 5 (2002) B29-B32
83. Medimmune Vaccines Incorporated. FluMist [package insert] (2007), Medimmune Vaccines, Inc., Gaithersburg (MD). http://www.flumist.com/pdf/flumist-prescribing-information.pdf Accessed January 22, 2008
84. Schmidt A.C. Antiviral therapy for influenza: a clinical and economic comparative review. Drugs 64 (2004) 2031-2046
85. Kaiser L., Wat C., Mills T., et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 163 (2003) 1667-1672
86. Monto A.S., Fleming D.M., Henry D., et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis 180 (1999) 254-261
87. Hayden F.G., Atmar R.L., Schilling M., et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 341 (1999) 1336-1343
88. Hayden F.G., Gubareva L.V., Monto A.S., et al. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med 343 (2000) 1282-1289
89. Robinson K.A., Baughman W., and Rothrock G. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. Opportunities for prevention in the conjugate vaccine era. JAMA 285 (2001) 1729-1735
90. CDC. Preventing pneumococcal disease among infants and young children. MMWR Morb Mortal Wkly Rep 49 (2000) 1-35
91. World Health Organization. Pneumococcal vaccines. Wkly Epidemiol Rec 14 (2003) 110-119
92. CDC. Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program (EIP) Network, 2000. Available at:. http://www.cdc.gov/ncidod/dbmd/abcs/survreports/spneu98.pdf Accessed January 22, 2008
93. Whitney C.G., Farley M.M., and Hadler J. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
94. Lucero M.G., Dulalia V.E., Parreno R.N., et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev 4 (2004) CD004977
95. Fedson D.S. The clinical effectiveness of pneumococcal vaccination: a brief review. Vaccine 17 Suppl 1 (1999) S85-S90
96. Eskola J., Kilpi T., Palmu A., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
97. National Center for Health Statistics. Early release of selected estimates based on data from the January-September National Health Interview Survey (NHIS) [monograph on the Internet] (2003), Centers for Disease Control and Prevention, Atlanta (GA). http://www.cdc.gov/nchs/about/major/nhis/released200303.htm#5 Accessed January 22, 2008
98. CDC. Pneumococcal polysaccharide vaccine-what you need to know. Available at:. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-ppv.pdf Accessed January 22, 2008
99. Fedson D.S., and Musher D.M. Pneumococcal vaccine. In: Plotkin S.A., and Mortimer Jr. E.A. (Eds). Vaccines. 2nd edition (1994), WB Saunders, Philadelphia 517-563
100. Weitzel K.W., and Goode J.V. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc (Wash) 40 (2000) 252-256
101. Singleton J.A., Poel A.J., Lu P.J., et al. Where adults reported receiving influenza vaccination in the United States. Am J Infect Control 33 (2005) 563-570
102. Mosesso Jr. V.N., Packer C.R., McMahon J., et al. Influenza immunization by EMS agencies: the MEDICVAX Project. Prehosp Emerg Care 7 (2003) 74-78